Medical device and MedTech insights, news, tips and more

Allotrope Medical announces FDA Safer Technologies Program (STeP) designation for their surgical device StimSit

November 7, 2022

StimSite

Allotrope Medical™ Inc., a company committed to advancing surgical efficiency and safety, announced that they have received Safer Technologies Program (STeP) designation from the FDA for their surgical device StimSite. For the past year, StimSite has been used by surgeons to help locate and identify ureters through electrical stimulation. This designation, along with a proposed additional indication for use, reflects StimSite’s value that while performing cystoscopy during open or minimally invasive surgical procedures, the device may decrease the time for functional urodiagnostic tests to confirm intact ureters.

With millions of lower abdominal and pelvic procedures performed every year including hysterectomies, endometriosis excisions and colon resections, there is a need for a simple, seamless, cost-effective technology that supports the surgeon and staff with awareness and verification of the ureter during surgery. Since StimSite’s FDA clearance in late 2020, surgeons across the United States have been using the technology to improve their operative experience through rapid ureter verification during all steps of the operation. During use of StimSite, surgeons also observed an increased predictability and decreased duration of their post-procedure cystoscopies.

“Surgeons are constantly learning new techniques, either robotics or laparoscopic, and safety is always front and center. StimSite allows a surgeon to rapidly verify its identity, create ureteral awareness during the case, and potentially have a substantial impact on shortening cystoscopies at the end of the case.  All these benefits align with the FDA’s Safer Technologies Program and are well-deserved,” commented Dr. Craig McCoy, a well-known urogynecologist and one of the technology’s early adopters.

Dr. Richard Farnam, a world leader in robotic gynecologic surgery, added “Stimsite is a game changer. I now have ‘on-demand’ ureter identification with induced vermiculation. The technology is seamlessly integrated into my surgical procedure and robotic workflow. How much is your time worth? I use StimSite to facilitate ureter efflux, and have observed a significant reduction in my post-procedure cystoscopy time.”

“We are both excited and honored to be part of the FDA’s Safer Technologies Program,” says Dr. Albert Huang, founder and CEO of Allotrope Medical. “I created StimSite to advance efficiency and safety for those operating in the pelvis, and these advancements now in the post-procedure cystoscopy space continue to show how we are improving the surgical experience for the OR team, surgeons and most importantly, the patients in a way that no other technology out there is able to.”

About StimSite

StimSite is a device intended to provide electrical stimulation to ureter smooth muscle tissue to help locate and identify ureters by testing ureter smooth muscle excitability. Able to be installed in seconds into any operating room, the device provides surgeons with the ability to elicit visible, full-length ureteral movement on demand using their existing laparoscopic and robotic instruments to deliver the stimulation signal. This allows the surgeon to have real-time ureteral awareness at all steps of the operation without changing instruments.

About Allotrope Medical Inc.

Allotrope Medical is a Houston-based company committed to helping surgeons increase efficiency and safety in millions of pelvic operations performed every year. Their product, StimSite, is designed to provide surgeons with ureteral awareness at all steps of their operation with seamless workflow and instrument integration. For more information, please visit www.allotropemed.com

See Full Press Release at the Source: Allotrope Medical announces FDA Safer Technologies Program (STeP) designation for their surgical device StimSite


Press Release by: Allotrope Medical


Legacy MedSearch has more than 35 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 17 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs.

We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.

Are you hiring?
Contact us to discuss partnering with Legacy MedSearch on your position.

More insights

February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More
October 12, 2023
Brainomix and Nanoflex Robotics to Collaborate on an AI-Assisted Robotic System for Remote Stroke Intervention
Learn More
October 10, 2023
FDA clears Intelivation Technologies new Hammerdesis™ Interphalangeal Fusion System
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.